Resono Ophthalmic Srl

Resono Ophthalmic Srl Resono Ophthalmic is an innovative Italian SME founded in 2014 to develop and sell cutting-edge therapeutic devices for Ophthalmology.

Resono Ophthalmic is an Italian company developing therapeutical devices for Ophthalmology based on QMR®, a patented technology that stimulates the natural regeneration of cells. The key feature of our devices is the Quantum Molecular Resonance (QMR®) treatment. It is a patented technology that stimulates the natural regeneration of cells and tissue by delivering low-power, high-frequency electrical fields. We first applied this technique to treat Dry Eye Disease (DED) with Rexon-Eye®, a patented CE-marked medical device. Clinical trials in Italy and abroad have provided scientific evidence that Rexon-Eye® is a safe, effective, and long-term treatment option for all types of DED. The benefits of QMR® in stimulating cell and tissue regeneration are currently under investigation also for its possible application in other eye diseases. For more information about technical and clinical details, please visit our website.

*QMR® is a registered trademark by Telea Electronic Engineering.

Rexon-Eye at SITRAC - Expanding the awareness of a comprehensive technology for ophthalmologyWith our national partner S...
18/02/2026

Rexon-Eye at SITRAC - Expanding the awareness of a comprehensive technology for ophthalmology

With our national partner SIR Oftalmica SRL Rexon-Eye and technology had the pleasure of attending the National Congress of SITRAC - Società Italiana Trapianto di Cornea e Superficie Oculare (Italian Society for Corneal Transplantation and Ocular Surface).
It was a valuable opportunity to share our vision of innovation and to highlight the inclusiveness and broad potential that QMR technology brings to the field of ophthalmology.

A special thank you to the entire SIR team for their commitment, and to Dr. Andrea Bedei for his insightful presentation on our technology.

Get in touch with our partner 👉 https://lnkd.in/g9jvteuX

Rexon-Eye and the powerful synergy between professionals and innovationWe had the pleasure of welcoming our partner VIÚ ...
13/02/2026

Rexon-Eye and the powerful synergy between professionals and innovation

We had the pleasure of welcoming our partner VIÚ 20/20 from Spain, along with Dr. Andrea Oleñik Memmel, ophthalmologist specialized in retina and ocular surgery, for a valuable exchange of expertise in the management of eye diseases.

By sharing knowledge, experience, and best practices, we strengthen our network and expand awareness of comprehensive dry eye solutions, such as

We look foward to continuing this collaborative journey.

Rexon-Eye and the powerful synergy between professionals and innovationWe had the pleasure of welcoming our partner VIÚ ...
13/02/2026

Rexon-Eye and the powerful synergy between professionals and innovation

We had the pleasure of welcoming our partner VIÚ 20/20 from Spain, along with Dr. Andrea Oleñik Memmel, ophthalmologist specialized in retina and ocular surgery, for a valuable exchange of expertise in the management of eye diseases.
By sharing knowledge, experience, and best practices, we strengthen our network and expand awareness of comprehensive dry eye solutions, such as

We look foward to continuing this collaborative journey.

Diving into regeneration at FACO Elche in SpainLast week, Rexon-Eye was present at the FACO Elche Congress together with...
10/02/2026

Diving into regeneration at FACO Elche in Spain

Last week, Rexon-Eye was present at the FACO Elche Congress together with our official partner for Spain, VIU 20/20 sharing with great commitment the powerful benefits and clinical achievements of Rexon-Eye with the ophthalmic community.

A special highlight was the speech by Dra. MERCEDES CABEZAS from IOFT - Instituto Oftalmológico de Toledo, who shared her clinical experience during the symposium dedicated to the application of Rexon-Eye and QMR technology in the treatment of Dry Eye Disease.

A heartfelt thank-you to our partner and to Dra. Cabezas Leon for their commitment and great energy.

Diving into regeneration at FACO Elche in SpainLast week, Rexon-Eye was present at the FACO Elche Congress together with...
10/02/2026

Diving into regeneration at FACO Elche in Spain

Last week, Rexon-Eye was present at the FACO Elche Congress together with our official partner for Spain, VIÚ 20/20 sharing with great commitment the powerful benefits and clinical achievements of Rexon-Eye with the ophthalmic community.

A special highlight was the speech by Dra. MERCEDES CABEZAS from IOFT - Instituto Oftalmológico de Toledo, who shared her clinical experience during the symposium dedicated to the application of Rexon-Eye and QMR technology in the treatment of Dry Eye Disease.

A heartfelt thank-you to our partner and to Dra. Cabezas Leon for their commitment and great energy.

05/02/2026

Ocular surface regeneration: The Efficacy of

Rexon-Eye offers a powerful approach to treating the entire ocular surface, addressing specific conditions that also affect the eyelids, such as blepharitis, which can lead to a loss of tissue functionality.

Among our most respected testimonials is Prof. Jose Manuel Benitez-del-Castillo, expert of ocular surface and professor from university Universidad de Madrid, Spain, who actively uses Rexon-Eye.
Our heartfelt thanks to Prof. Benítez for sharing his great experience and for his continued commitment.

Get more information 👉🏼 https://rexoneye.com

The proof of comprehensive technology in actionThe clinical experience of Dr.Giovanni Roberto Tedesco demonstrates the p...
05/02/2026

The proof of comprehensive technology in action

The clinical experience of Dr.Giovanni Roberto Tedesco demonstrates the powerful application of QMR technology and Rexon-Eye in the treatment of all forms of Dry Eye: evaporative, aqueous-deficient, and mixed.

Thanks to their regenerative effects on ocular tissues and glands, the tear film layers are restored, delivering long-term benefits and improved quality of life for patients.

A special thank you to our KOL Dr. Tedesco for sharing his valuable clinical experience.

Get more information on the protocol 👉 https://rexoneye.com/

QMR at Low Vision Academy 2026, BolognaLast week, the “Congresso Nazionale per Ipovisione” took place, giving us the opp...
30/01/2026

QMR at Low Vision Academy 2026, Bologna

Last week, the “Congresso Nazionale per Ipovisione” took place, giving us the opportunity to present the potential of technology applied to the treatment of ocular diseases. A valuable moment to showcase our latest achievements, and the beginning of exciting new developments.

A special thank you to Prof. Sergio Zaccaria Scalinci for leading the event, and to Prof. Luigi Donato and his team of Università di Messina for sharing their clinical results and spreading the message: “the future of medicine lies in regeneration”.

Stay tuned: https://rexoneye.com/it/

QMR at Low Vision Academy 2026, BolognaLast week, the "Congresso Nazionale per Ipovisione" took place, giving us the opp...
27/01/2026

QMR at Low Vision Academy 2026, Bologna

Last week, the "Congresso Nazionale per Ipovisione" took place, giving us the opportunity to present the potential of technology applied to the treatment of ocular diseases. A valuable moment to showcase our latest achievements, and the beginning of exciting new developments.

A special thank you to Prof. Sergio Zaccaria Scalinci for leading the event, and to Prof. Luigi Donato and his team of Università di Messina for sharing their clinical results and spreading the message: "the future of medicine lies in regeneration".

Stay tuned: https://rexoneye.com/it/

hashtag

Resono team would like to extend our warmest holiday wishes to all of you.May this festive season bring you rest, joy, a...
23/12/2025

Resono team would like to extend our warmest holiday wishes to all of you.
May this festive season bring you rest, joy, and renewed energy.

We look forward to coming together in the new, inspiring, and promising year ahead, filled with exciting milestones and continued innovation in eye care

- powerful benefits for gamers Dr. Andres Benatti, Cornea and refractive surgeon, has developed a protocol with Rexon-...
04/12/2025

- powerful benefits for gamers
 
Dr. Andres Benatti, Cornea and refractive surgeon, has developed a protocol with Rexon-Eye to treat a specific and particular category affected most of the time by Dry Eye: Gamers and Content Creators.

This new generation of professionals spends long hours in front of screens, whether studying or working. Over time, their visual performance and productivity can decline due to alterations in the ocular surface.
With Rexon-Eye and QMR technology, the tear film is optimized and visual comfort is improved.
 
A special thank you to our esteemed Key Opionion Leader for sharing his valuable clinical experience
 
Discover more about the protocol: https://rexoneye.com/

12/11/2025

The treatment of Neuropathic Corneal Pain lies in regeneration

With Professor Yu-Chi Liu, corneal specialist and clinician scientist at the Singapore National Eye Centre and Associate Professor at Duke–National University of Singapore, a clinical study is currently underway on the treatment of Neuropathic Corneal Pain with Rexon-Eye and Technology.
This ongoing study has already shown very promising results, demonstrating the efficacy of QMR in regenerating the corneal nerves.

A heartfelt thank you to Professor Yu-Chi Liu and her institution for their invaluable collaboration.

Watch the full interview 👉 https://lnkd.in/djXkMcts

Indirizzo

Sandrigo

Orario di apertura

Lunedì 09:00 - 18:00
Martedì 09:00 - 18:00
Mercoledì 09:00 - 18:00
Giovedì 09:00 - 18:00
Venerdì 09:00 - 18:00

Sito Web

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Resono Ophthalmic Srl pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Resono Ophthalmic Srl:

Scelte rapide

Condividi

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Digitare

REinvent Dry Eye treatment

The company RESONO OPHTHALMIC Srl is a young italian company founded in 2014 whose main activities are focused on the development and marketing of highly innovative therapeutic devices with application in the various scopes of ophthalmology.

The key feature of these devices is the use of Quantum Molecular Resonance (QMR), a patented technique that stimulates natural cellular and tissue regeneration through low-frequency high-frequency electric fields. The first clinical application concerns the dry eye syndrome (DES) with the REXON-EYE instrument (Italian and European patents, the US being registered), a medical device that has already obtained the CE mark.

Clinical trials in Italy and abroad, already completed or in progress, have clearly shown that Rexon-Eye is a safe and effective treatment option to improve subjective and objective symptoms in DES. The benefits of QMR in stimulating natural cell and tissue regeneration are currently being studied for potential application to other eye conditions, paving the way for the development of a family of ophthalmic therapeutic tools based on the QMR.